Various
Ended Awarded Last action
- Contract number
- N6890816F0114
- Awardee
-
Immucor Inc. UEI KV8AGJX7NMZ7
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $153,884
Award facts
- Contract value 100% obligated
- $153,884.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Camp Lejeune, NC 28547, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $29,804 | |
| Exercise an Option | $0 | |
| Exercise an Option | $29,804 | |
| Exercise an Option | $29,804 | |
| Exercise an Option | $29,804 | |
| Funding Only Action | $400 | |
| Change Order | -$33,639 | |
| Original award | $67,908 |
About this award
This is a delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract is for the supply of PANOCELL I, II, III (3X10ML) medical products, with a ceiling value of $153,884.39 and a period of performance through September 30, 2021. The contract was awarded on a firm fixed-price basis without any set-aside designation. Immucor is the prime contractor and no subcontractors are mentioned. This contract is part of a larger Blanket Purchase Agreement (BPA) held by Immucor with the Defense Health Agency, valued at up to $1,020,000 and effective through March 2027. The products provided under this contract support critical medical testing and healthcare operations across various federal networks.
Quick answers
Who was awarded contract N6890816F0114?
N6890816F0114 was awarded to Immucor Inc. by Bureau of Medicine and Surgery (Department of the Navy) on October 1, 2017.
How much is contract N6890816F0114 worth?
The government has obligated $153,884 on N6890816F0114.
Which agency awarded contract N6890816F0114?
Bureau of Medicine and Surgery (Department of the Navy) awarded N6890816F0114, with funding from Defense Health Agency (Department of Defense).
Is contract N6890816F0114 an order under another contract?
Yes. N6890816F0114 is a delivery order under V797P5944X, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract N6890816F0114 competed?
The extent of competition for N6890816F0114 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award